Considering the above, this study was designed to evaluate the yet unknown dynamics of changes in the levels of GAAGs, COMP, and YKL-40-as potential biomarkers of dysfunctions of the osteoarticular system and the efficacy of biological therapy in the blood of JIA patients before and during 2 years of treatment with TNF-α inhibitors. This evidence concerns the gene COMP and juvenile idiopathic arthritis.